By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cancer and Leukemia Group B 

230 West Monroe, Suite 2050

Chicago  Illinois  60606  U.S.A.
Phone: 773-702-9171 Fax: 312-345-0117


Company News
Cancer and Leukemia Group B Release: Data from Phase II Clinical Trial of Galiximab in Combination with Rituximab in Patients with Previously Untreated Follicular Lymphoma Presented at International Conference on Malignant Lymphoma 6/9/2008 8:56:34 AM
Cancer and Leukemia Group B Presents Results At American Society of Clinical Oncology From Randomized Study Of Cetuximab And Chemotherapy In First-Line Metastatic Colorectal Cancer 6/6/2006 1:49:41 PM
Cancer and Leukemia Group B And Southwest Oncology Group To Evaluate The Addition Of Erbitux To Chemotherapy Or Chemotherapy And Avastin In First-Line Metastatic Colorectal Cancer10/19/2005 5:12:55 PM
Cancer and Leukemia Group B (CALGB) Release: Significant Improvements In Efficacy With Weekly Chemotherapy (Paclitaxel) Compared To Standard 3-Weekly Therapy In Women With Advanced Breast Cancer10/19/2005 5:11:40 PM